Nafees Malik
Corporate Officer/Principal bei Juvenescence, Inc.
Profil
Nafees N.
Malik was the founder of Asklepian Consulting Ltd.
founded in 2013, where he held the title of Managing Director.
Currently, he is the Head-Cell & Gene Therapy at Juvenescence, Inc. since 2018.
He was the Chief Operating Officer at AgeX Therapeutics, Inc. from 2018 to 2023.
Dr. Malik holds a doctorate degree from The University of Liverpool and a graduate degree from the University of Cambridge.
Aktive Positionen von Nafees Malik
| Unternehmen | Position | Beginn |
|---|---|---|
| Juvenescence, Inc. | Corporate Officer/Principal | 01.10.2018 |
Ehemalige bekannte Positionen von Nafees Malik
| Unternehmen | Position | Ende |
|---|---|---|
| AGEX THERAPEUTICS, INC. | Chief Operating Officer | 27.12.2023 |
| Asklepian Consulting Ltd. | Chief Executive Officer | - |
Ausbildung von Nafees Malik
| The University of Liverpool | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
| Juvenescence, Inc. | Miscellaneous |
| Asklepian Consulting Ltd. |
